HumanaMedicare Advantage · Coverage · Medicare Advantage · Gastroenterology, Family Medicine, Internal Medicine +1 moreMedium impact
Colorectal Cancer Screening - Medicare Advantage (Revised)
Effective date
Jun 8, 2026
Identified
Jun 24, 2026
Summary
Humana Medicare Advantage has revised their colorectal cancer screening policy effective June 8, 2026, with review scheduled for March 10, 2026. This policy update provides comprehensive coverage guidelines for various screening methods including endoscopic, laboratory, and radiologic approaches, with specific exclusions for certain genetic tests.
Get alerts when payers change rules like this one
We check Humana and other payers every day and email you when a change matches your specialty and state.
01Before June 8, 2026: Billing team must review current colorectal cancer screening billing practices for Humana Medicare Advantage members.
02Ensure CPT code 81327 (SEPT9 genetic test) is not billed as it remains statutorily excluded.
03Verify that all colorectal screening services align with the updated policy guidelines and related MAC LCD requirements for your geographic jurisdiction.
04Update billing system edits to flag excluded services.
Codes mentioned
81327
Original notice
Colorectal Cancer Screening - Medicare Advantage (Revised)
mcp.humana.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.